Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasitibant in Knee Osteoarthritis (ALBATROSS)
NCT01091116Phase 2Completed
- Sponsor
- Menarini Group
- Start
- Mar 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of fasitibant in osteoarthritis (OA), sponsored by Menarini Group. Started Mar 2010; status: completed.
02
Drugs
fasitibant
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01091116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091116.